Chimeric antigen receptor T cell (CAR-T) therapy is a novel cellular immunotherapy method that introduces chimeric antigen receptors and costimulatory molecules targeting specific targets into T cells by gene editing technology. TumorRead More…
CAR-NK: Safer, Cheaper and Better Anti-cancer Drug
At the end of June this year, the CAR-NK cell, a new immune cell, was reported as the third CAR cell to fight against cancer after CAR-T cells and CAR-macrophage cells. TheRead More…
PD1 VS CTLA-4: Which Works Better in the Combination Therapy with Oncolytic Virus?
Cancers don’t come from anything but result from unexpected mutations in human cells with the uncontrolled proliferation of cells as the most important feature. The cells in the body undergo mutations atRead More…
Hot Issues Tracking—Present and Future of Oncolytic Virus
On May 2, Johnson & Johnson, a pharmaceutical giant, announced that it has invested $1 billion in the acquisition of BeneVir Biopharm, a biotech-company dedicated to oncolytic virus immunotherapy research. This newsRead More…
What Is Immunotherapy？
A 72-year-old Connecticut citizen Bob Carlson was diagnosed with lung cancer four years ago. The doctor estimates that he will not live longer than two years. He tried a variety of programsRead More…
CAR-T: A Constantly Optimized Anti-cancer Therapy
CAR-T cell immunotherapy, the chimeric antigen receptor T-cell immunotherapy, is a highly efficient and advanced cell immunotherapy. The principle is to genetically modify the immune cell T cells in patients to killRead More…
Science: Harvard Discovered Antibody Immunotherapeutics to Help NK Cells Destroy Cancer Cells
There is no doubt that the emergence of immunotherapy has redefined the field of cancer treatment as breakthrough progress. Most immunotherapies now focus on the adaptive immune response, that is, onRead More…
Natrue: Altered Immune Cells Can Eliminate Childhood Brain Tumor in Mice
A study at the Stanford University School of Medicine showed that altered immune cells can eliminate a fatal pediatric brain tumor in a mouse model, which was published in the AprilRead More…
What Are IL-7 & CCL19 CAR-T Cells?
Recently, Japanese scientists have developed a new type of chimeric antigen receptor T cell called 7 × 19 CAR-T cell. This new generation of CAR-T cells target hCD20 antigen and showed aRead More…
Nat Biotechnol: New Generation of CAR-T Can Easily Eliminate Solid Tumors
Huge progress has been made in the CAR-T field recently. Professor Koji Tamada from Yamaguchi University, Department of Immunology, has successfully developed a new generation of CAR-T. Meanwhile, in a variety of solidRead More…